| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JNJ | Common Stock | Options Exercise | $1,302,281 | +13,015 | $100.06 | 13,015 | 07 Feb 2025 | Direct | F1 | |
| transaction | JNJ | Common Stock | Sale | $2,002,878 | -13,015 | -100% | $153.89 | 0 | 07 Feb 2025 | Direct | F2 |
| holding | JNJ | Common Stock | 68,835 | 07 Feb 2025 | By SLAT | F3 | |||||
| holding | JNJ | Common Stock | 2,113 | 07 Feb 2025 | By 401k | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JNJ | Employee Stock Options (Right to Buy) | Options Exercise | $1,302,281 | -13,015 | -100% | $100.06 | 0 | 07 Feb 2025 | Common Stock | 13,015 | $100.06 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Reflects the exercise of options immediately prior to their expiration. |
| F2 | This transaction was executed in multiple trades at prices ranging from $153.86 to $153.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary. |
| F4 | Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025). |